123 related articles for article (PubMed ID: 3611879)
1. [New combination chemotherapy against drug-resistant choriocarcinoma].
Matsui H; Kobayashi O; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1087-94. PubMed ID: 3611879
[TBL] [Abstract][Full Text] [Related]
2. [A study of first and second line chemotherapies in gestational choriocarcinoma].
Matsui H; Eguchi O; Inaba N; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1297-304. PubMed ID: 8258729
[TBL] [Abstract][Full Text] [Related]
3. [Basic and clinical study of anticancer effect of etoposide on choriocarcinoma].
Fujii T; Maeda M
Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):593-600. PubMed ID: 3385278
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
5. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
Newlands ES
Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
[TBL] [Abstract][Full Text] [Related]
6. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
7. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
Matsui H; Suzuka K; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
[TBL] [Abstract][Full Text] [Related]
8. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
9. [Study on the rationale for chemotherapy of refractory choriocarcinoma].
Katoh T; Ishige H; Kobayashi O; Takamizawa H
Gan To Kagaku Ryoho; 1982 May; 9(5):815-21. PubMed ID: 6191704
[TBL] [Abstract][Full Text] [Related]
10. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
11. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
Lurain JR; Brewer JI
Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
[TBL] [Abstract][Full Text] [Related]
12. [Methotrexate in gynecologic oncology].
Isonishi S; Terashima Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
[TBL] [Abstract][Full Text] [Related]
13. Management of high-risk gestational trophoblastic disease.
Lurain JR
J Reprod Med; 1998 Jan; 43(1):44-52. PubMed ID: 9475149
[TBL] [Abstract][Full Text] [Related]
14. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
15. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
[TBL] [Abstract][Full Text] [Related]
16. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
Mortakis AE; Braga CA
Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
[TBL] [Abstract][Full Text] [Related]
17. [The treatment of refractory choriocarcinoma].
Takamizawa Y; Inaba N; Matsui H
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1843-7. PubMed ID: 2393304
[TBL] [Abstract][Full Text] [Related]
18. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Wang S; An R; Han X; Zhu K; Xue Y
Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
[TBL] [Abstract][Full Text] [Related]
20. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]